Found 43 matching trials
CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) PHASE1 The aim of this clinical trial is to evaluate the feasibility, safety and b...
Show More Location
Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum
Learn More & Join Trial
Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma PHASE1 In this study, investigators are trying to see if LMP specific cytotoxic T ...
Show More Location
Childrens National Medical Center
Learn More & Join Trial
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases PHASE1 Patients have a type of a lymph node cancer called lymphoma, a tumor of the...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies PHASE2 This is a Phase II trial to evaluate the efficacy and safety of human leuko...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA) PHASE1 Patients have a type of cancer called nasopharyngeal carcinoma (NPC) which ...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer PHASE1 Nasopharyngeal cancer (NPC) is a cancer that starts at the back of the nose...
Show More Location
Princess Margaret Hospital
Learn More & Join Trial
A Phase III Trial Evaluating Chemotherapy and Immunotherapy for Advanced Nasopharyngeal Carcinoma (NPC) Patients PHASE3 This study is a multi-center, randomized, open label, Phase III clinical tr...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma PHASE1 This protocol is broken up into 2 portions to determine the maximum tolerat...
Show More Location
Texas Children's Hospital
Learn More & Join Trial
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant PHASE1 This phase I/II trial studies the safety and toxicity of post-transplant tr...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies PHASE1 The purpose of this study is to test the safety of giving the patient speci...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial